Concepedia

Michael Golden

MG

Statistics

Publications

6

Citations

229

H-Index

6

Active since

2007

Affiliations

AstraZeneca (United Kingdom)(Current)

AstraZeneca (Poland)

AstraZeneca (Singapore)

Michael Golden is an author at AstraZeneca (United Kingdom) specializing in medicinal chemistry, life sciences, and transaminase catalysis.

ORCID

Publications per year

2007–2016

6

Publications

6

Use of ω-Transaminase Enzyme Chemistry in the Synthesis of a JAK2 Kinase Inhibitor

Lianne Frodsham, Michael Golden, Susan Hard et al. · Organic Process Research & Development · 2013 · 55 citations

, , +13

Development of a Manufacturing Route to Avibactam, a β-Lactamase Inhibitor

Matthew Ball, Alistair Boyd, Gareth J. Ensor et al. · Organic Process Research & Development · 2016 · 50 citations

, , +16

Efficient Synthesis of (<i>S</i>)-1-(5-Fluoropyrimidin-2-yl)ethylamine Using an ω-Transaminase Biocatalyst in a Two-Phase System

Rebecca E. Meadows, Keith R. Mulholland, Martin Schürmann et al. · Organic Process Research & Development · 2013 · 44 citations

, , +15

Asymmetric synthesis of (S)-(−)-N-acetylcolchinol via Ullmann biaryl coupling

Simon D. Broady, Michael Golden, John Leonard et al. · Tetrahedron Letters · 2007 · 42 citations

, , +8

Isoindolone Formation via Intramolecular Diels–Alder Reaction

Matthew Ball, Alistair Boyd, Gwydion Churchill et al. · Organic Process Research & Development · 2012 · 28 citations

, , +8

1–5 of 6